# Aino Health

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/ainohealth).

## Overview

Aino Health is a Swedish software company focused on work ability management and employee wellbeing. Its SaaS platform helps employers monitor, prevent, and manage health-related absence and work capacity across large workforces, with customers mainly in Finland and other European markets.

## Products & services

• SaaS platform for work ability management
• Employee wellbeing and absence monitoring tools
• Customer onboarding and implementation services
• Ongoing customer success and platform support
• Occupational health and wellbeing partnership solutions

- **SaaS subscriptions** (80%) — Recurring software licenses for Aino's work ability management platform.
- **Implementation and onboarding services** (12%) — Project-based services to deploy the platform for new customers and rollouts.
- **Customer success and support** (8%) — Ongoing support, adoption, and account management tied to active customers.

- SaaS platform for work ability management
- Employee wellbeing and absence monitoring tools
- Customer onboarding and implementation services
- Ongoing customer success and platform support
- Occupational health and wellbeing partnership solutions

## Customers

Aino Health sells to organizations with large, complex workforces that need systematic tools for employee wellbeing and work capacity management. Reported wins include manufacturing groups, shipbuilders, healthcare operators, public-sector occupational health providers, and industrial automation companies. Customers buy the platform to improve proactive management, support productivity, and standardize wellbeing processes across many employees.

- **Large industrial employers** (primary) — Manufacturing, shipbuilding, and automation customers buy the platform to manage work ability across sizable frontline workforces.
- **Healthcare and welfare organizations** (secondary) — Healthcare operators and welfare organizations use the platform to support employee wellbeing and reduce work ability risks.
- **Occupational health providers** (secondary) — Providers implement or distribute the SaaS platform as part of broader occupational health services.
- **Public-sector employers** (secondary) — Public organizations buy the platform to improve proactive work ability management and employee wellbeing.

- Large employers with complex, distributed workforces
- Manufacturing groups seeking proactive absence and wellbeing tools
- Healthcare and public-sector organizations
- Industrial and shipbuilding customers with operationally critical staff
- Occupational health providers that resell or implement the platform

## Geography

Aino Health is headquartered in Sweden and appears to generate most of its revenue in Finland, where many of its reported customer deployments are concentrated. The company also targets broader European expansion through partnerships and new customer wins in the UK and other European markets.

- Headquartered in Sweden
- Majority of reported turnover came from Finland
- Customer deployments reported in Finland and other European markets
- UK partnership supports broader European reach
- International growth is tied to new customer rollouts and partnerships

## Strategy

Aino Health is focused on expanding its recurring license base, improving pricing discipline, and converting new customer wins into broader rollouts within existing accounts. It is also building international reach through financing support, partnerships, and product development aimed at large-workforce employers.

- **Expand the license base** (short-term) — More active users increase recurring revenue and deepen customer penetration.
- **Improve pricing discipline** (short-term) — Value-based pricing supports recurring revenue quality and long-term sustainability.
- **Drive successful implementations and rollouts** (short-term) — Onboarding quality affects retention, adoption, and expansion within accounts.
- **International expansion through partnerships and financing** (medium-term) — External partners and funding help support market entry beyond the core Nordic base.

- Grow the installed license base through new wins and rollouts
- Strengthen recurring revenue quality through value-based pricing
- Expand within existing customers via phased deployments
- Target sectors with large, complex workforces
- Use partnerships to accelerate international market access

## Risks

Aino Health’s business depends on winning and retaining recurring software customers, so pricing changes, customer churn, and slow enterprise decision-making can affect growth. The company also faces financing and execution risk because it must fund product development, onboarding, and international expansion while managing a relatively concentrated customer base.

- **Need for additional capital** [high] — The company states it may need to raise more capital or obtain cofinancing to support growth.
- **Customer churn and contract loss** [high] — Recurring revenue depends on retaining customers; one major relationship ended due to customer financial circumstances.
- **Pricing pressure and renewal volatility** [medium] — Value-based pricing can improve long-term economics but may cause short-term revenue fluctuations.
- **Key personnel dependence** [medium] — Loss of key staff could hurt product development, customer delivery, and sales execution.

- Customer churn can reduce recurring revenue and active licenses
- Value-based pricing may create short-term volatility in renewals
- Capital needs could limit product development and growth investment
- Key personnel loss could disrupt sales, delivery, and product work
- Enterprise sales cycles can be slow and unpredictable

## Accounting

Aino Health’s reporting is shaped by recurring SaaS revenue, implementation work, and customer onboarding, so revenue timing and contract mix matter for comparability. The company also notes that it has not capitalized product development costs in the quarter, which affects the balance between expensed development and future intangible asset creation.

- **Revenue recognition for SaaS and services** — Mix between licenses and services can shift reported revenue timing
- **Development cost capitalization** — Affects operating profit and intangible asset balances
- **Going-concern and liquidity assessment** — Important for assessing funding needs and continuity
- **Quarterly seasonality and rollout timing** — Can make quarter-to-quarter comparisons noisy

- SaaS revenue recognition depends on contract timing and service delivery
- Implementation and onboarding work can shift revenue between periods
- No capitalization of product development costs affects reported expenses
- Quarterly results may be affected by customer rollout timing
- Liquidity and going-concern judgments can influence disclosure emphasis

---

*Last updated: 2026-08-11T04:04:50.773792+00:00*